A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol

Table 1 Inclusion and Exclusion criteria

Criteria
Inclusion	Established liver cirrhosis according to clinical practice criteria Age ≥ 18 years Signed informed consent
Exclusion	Contraindications to perform MRI (pacemaker, ferrous metal implants/fragments, claustrophobia, extreme obesity, and/or pregnancy) Diagnosis of primary sclerosing cholangitis Diagnosis of hepatocellular carcinoma Previous liver transplant

ISSN: 1471-230X